Biopharma Financing Biopharma financings during the third quarter of 2022 totaled $18.1bn from 236 deals. The largest was a $1.39bn royalty sale by Theravance Biopharma to Royalty Pharma , which acqu
Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc